← Back to Clinical Trials
Recruiting NCT07007598

NCT07007598 Prevention of Post-Polypectomy Colorectal Bleeding by Clips in Patients on Anticoagulants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07007598
Status Recruiting
Phase
Sponsor Helios Kliniken Schwerin
Condition Polyp of Colon
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2025-05-01
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Hemostatic clip

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2025-05-01 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to retrospectively determine if clips can prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy, using a large, single-center patient registry. The main question it aims to answer is: Can clips prevent post-polypectomy bleeding in adults who have received restarted anticoagulants after a colorectal polypectomy? Researchers will compare adults who received preventive clipping after a polypectomy with those who did not, regarding colorectal bleeding after receiving restarted anticoagulants. Participants have undergone a colorectal polypectomy and received restarted anticoagulants (acetylsalicylic acid excluded) after the procedure.

Eligibility Criteria

Inclusion Criteria: * adult who has received a colonoscopy with endoscopic colorectal polypectomy * patient who has received at least one anticoagulant after polypectomy Exclusion Criteria: * Endoscopic polypectomy was combined with closure of the mucosal defect by a suturing device or full thickness resection device

Contact & Investigator

Central Contact

Daniel Schmitz, Dr. med.

✉ Daniel.Schmitz@helios-gesundheit.de

📞 +493855202601

Principal Investigator

Daniel Schmitz, Dr.med.

PRINCIPAL INVESTIGATOR

Helios Kliniken Schwerin

Frequently Asked Questions

Who can join the NCT07007598 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Polyp of Colon. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07007598 currently recruiting?

Yes, NCT07007598 is actively recruiting participants. Contact the research team at Daniel.Schmitz@helios-gesundheit.de for enrollment information.

Where is the NCT07007598 trial being conducted?

This trial is being conducted at Schwerin, Germany.

Who is sponsoring the NCT07007598 clinical trial?

NCT07007598 is sponsored by Helios Kliniken Schwerin. The principal investigator is Daniel Schmitz, Dr.med. at Helios Kliniken Schwerin. The trial plans to enroll 10,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology